F. Lerebours
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in ⓘ
-
- Breast Cancer Treatment Studies 24
- Cancer Genomics and Diagnostics 5
- Oncology 33
- HER2/EGFR in Cancer Research 14
- Cancer Treatment and Pharmacology 13
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 4
- Co-authors
- Rosette Lidereau (4 shared papers)Roman Rouzier (13 shared papers)Marc Espié (4 shared papers)P Bertheau (1 shared paper)E Turpin (1 shared paper)Anne Janin (1 shared paper)Michel Marty (1 shared paper)Yves Beuzard (1 shared paper)
- Journals
- Annals of Oncology (13 papers)Cancer Research (7 papers)British Journal of Cancer (4 papers)Journal of Clinical Oncology (3 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
F. Lerebours
48 papers receiving 696 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 264
- Oncology 437
- Ophthalmology 53
- Pathology and Forensic Medicine 59
- Virology 15
Countries citing papers authored by F. Lerebours
This map shows the geographic impact of F. Lerebours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lerebours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lerebours more than expected).
Fields of papers citing papers by F. Lerebours
This network shows the impact of papers produced by F. Lerebours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lerebours. The network helps show where F. Lerebours may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Lerebours, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 126 | |
| 2 | 1987 | 71 | |
| 3 | Regulation of Ras-related RhoB protein expression during the cell cycle. | 1995 | 71 |
| 4 | 2017 | 68 | |
| 5 | 2014 | 51 | |
| 6 | 2017 | 35 | |
| 7 | 2002 | 31 | |
| 8 | 2015 | 28 | |
| 9 | 2002 | 27 | |
| 10 | 2012 | 26 | |
| 11 | 2018 | 22 | |
| 12 | 2021 | 19 | |
| 13 | 2015 | 14 | |
| 14 | 2015 | 11 | |
| 15 | 2021 | 9 | |
| 16 | 1999 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2020 | 9 | |
| 19 | [Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers]. | 1997 | 9 |
| 20 | 2015 | 8 |
About F. Lerebours
F. Lerebours is a scholar working on Cancer Research, Oncology, Family Practice, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 49 papers that have together received 713 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (14 papers), Cancer Treatment and Pharmacology (13 papers), Breast Lesions and Carcinomas (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (264 citations), Oncology (437 citations), Ophthalmology (53 citations), Pathology and Forensic Medicine (59 citations) and Virology (15 citations). F. Lerebours has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Rosette Lidereau, Roman Rouzier, Marc Espié, P Bertheau, E Turpin, Anne Janin, Michel Marty, Yves Beuzard, Hugues de Thé and François Plassa. Their work appears in journals such as Annals of Oncology, Cancer Research, British Journal of Cancer, Journal of Clinical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.